Tenax Therapeutics, Inc.

Release Summary

Tenax Therapeutics, Inc. (NASDAQ: TENX), highlights recently published meta-analysis of 14 clinical studies showing levosimendan decreased early mortality in patients with reduced ejection fraction.

Tenax Therapeutics, Inc.